A role for ezrin in a neglected metastatic tumor function

Trends in Molecular Medicine

Volumn 10, Issue 6, 2004, Pages 249-250

  Fais, Stefano ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; EZRIN; MEMBRANE PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ANTIGEN PRESENTING CELL; APOPTOSIS; EXTRACELLULAR MATRIX; HUMAN; HYPOXIA; MACROPHAGE; METASTASIS; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SHORT SURVEY; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; VASCULARIZATION;

ANIMALS; ANTIGENS, CD44; CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; PHAGOCYTOSIS; PHOSPHOPROTEINS;

EID: 2642522810     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2004.04.005     Document Type: Short Survey

References (23)

1. Hunter K.W., et al. Ezrin, a key component in tumor metastasis. Trends Mol. Med. 10:2004;201-204
2. Khanna C., et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat. Med. 10:2004;182-186
3. Yu Y., et al. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat. Med. 10:2004;175-181
4. Bretscher A. Regulation of cortical structure by the ezrin-radixin-moesin protein family. Curr. Opin. Cell Biol. 11:1999;109-116
5. Gautreau A., et al. ERM proteins and NF2 tumor suppressor: the Yin and Yang of cortical actin organization and cell growth signaling. Curr. Opin. Cell Biol. 1:2002;104-109
6. Fais S., Malorni W. Leukocyte uropod formation and membrane/cytoskeleton linkage in immune interactions. J. Leukoc. Biol. 73:2003;556-563
7. Martin T.A., et al. The role of the CD44/ezrin complex in cancer metastasis. Crit. Rev. Oncol. Hematol. 46:2003;165-186
8. Lugini L., et al. Potent phagocytic activity discriminate metastatic and primary human malignant melanoma: a key role of ezrin. Lab. Invest. 83:2003;1555-1567
9. Steinhaus J. Ueber carcinom-einschlüsse. Virchows Arch. 126:1891;533-535
10. Stroebe H. Zur kenntniss verschiedener cellulärer. Vorgänge und Erscheinungen in Geschwülten. Beitr. Pathol. 11:1892;1-9
11. Marin-Padilla M. Erythrophagocytosis by epithelial cells of brest carcinoma. Cancer. 39:1977;1085-1089
12. DeSimone P.A., et al. Phagocytic tumor cell activity in oat cell carcinoma of the lung. Hum. Pathol. 11:1980;535-539
13. Defacque H., et al. Involvement of Ezrin/Moesin in de novo actin assembly on phagosomal membranes. EMBO J. 19:2000;199-212
14. Moilanen J., et al. Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients. Gynecol. Oncol. 90:2003;273-281
15. Makitie T., et al. Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma. Invest. Ophthalmol. Vis. Sci. 42:2001;2442-2449
16. Clark E.A., et al. Genomic analysis of metastasis reveals an essential role for RhoC. Nature. 406:2000;532-535
17. Fiorentini C., et al. Activation of Rho GTPases by cytotoxic necrotizing factor 1 induces macropinocytosis and scavenging activity in epithelial cells. Mol. Biol. Cell. 12:2001;2061-2073
18. Townson J.L., et al. The role of apoptosis in tumor progression and metastasis. Curr. Mol. Med. 3:2003;631-642
19. Parlato S., et al. CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J. 19:2000;5123-5134
20. Lozupone F., et al. Identification and relevance of the CD95-binding domain in the N-terminal region of Ezrin. J. Biol. Chem. 279:2004;9199-9207
21. +T lymphocytes. Cell Death Differ. 11:2004;574-582
22. Luciani F., et al. P-glycoprotein/actin association through ERM family proteins: a role in P-glycoprotein function in human cells of lymphoid origin. Blood. 99:2002;641-648
23. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62:1993;385-427